People Data, Reporting & Analytics Manager at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s degree in HR, Business Analytics, Information Systems, or related field required
Minimum of 5 years of experience in HR reporting, analytics and dashboarding, ideally within a global organization
Strong hands-on experience with Workday — including Advanced Reporting, Calculated Fields, Dashboards

Responsibilities

Lead the design, development, and maintenance of Workday reports, scorecards, and dashboards supporting global HR metrics and KPIs
Provide data-driven insights to support workforce planning, talent management and operational reporting
Partner with HR Business Partners and Centers of Excellence (COEs) to define, track and report standardized global HR metrics
Build and maintain a library of recurring and ad hoc HR reports for leadership, compliance, and audits
Design and manage Power BI dashboards integrating data from Workday and other HR systems
Serve as the data steward for HR data, ensuring accuracy, consistency, and alignment across global regions
Collaborate with HRIS and IT to define and enforce data governance, definitions, and quality standards
Support data integration initiatives between Workday and other systems to ensure seamless analytics
Partner with internal audit, data privacy and compliance teams on data integrity and privacy best practices
Deliver actionable insights that help HR and business leaders make informed talent and organizational decisions
Identify trends and provide recommendations related to workforce performance, turnover, and engagement
Drive automation and process improvements to enhance reporting efficiency and reduce manual effort
Stay current on Workday analytics capabilities, Power BI advancements, and industry HR analytics best practices
Collaborate cross-functionally with HR, Finance, IT, and regional teams to ensure alignment of reporting and analytics processes
Use HR data and analytics to drive data-informed decisions across HR and business functions
Deliver clear, actionable insights that influence workforce and organizational strategies
Translate complex data into simple narratives that support leadership decision-making

Skills

Workday

Power BI

HR Reporting

Dashboards

Analytics

KPIs

Data Integrity

Workforce Planning

Talent Management

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free